Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs

Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

(2019) Sara Bandres‐Ciga et al.   ANNALS OF NEUROLOGY

Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis

(2019) Ching-Piao Tsai et al.   JOURNAL OF NEUROLOGY

Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis

(2018) Fuling Zhou et al.   BRAIN RESEARCH BULLETIN

Amyotrophic Lateral Sclerosis: An Update for 2018

(2018) Björn Oskarsson et al.   MAYO CLINIC PROCEEDINGS

Effects of Ovariectomy in an hSOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)

(2018) Lina Yan et al.   MEDICAL SCIENCE MONITOR

Causal Effects of Blood Lipids on Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study

(2018) Ping Zeng et al.   HUMAN MOLECULAR GENETICS

Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly

(2018) D. Michal Freedman et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015

(2018) Paul Mehta et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis

(2017) F. D'Ovidio et al.   EUROPEAN JOURNAL OF NEUROLOGY

Drugs in clinical development for the treatment of amyotrophic lateral sclerosis

(2017) Ana Martinez et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Amyotrophic lateral sclerosis

(2017) Michael A van Es et al.   LANCET

A case-control study of hormonal exposures as etiologic factors for ALS in women

(2017) James P.K. Rooney et al.   NEUROLOGY

ALS: A bucket of genes, environment, metabolism and unknown ingredients

(2016) Mónica Zufiría et al.   PROGRESS IN NEUROBIOLOGY

The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives

(2015) Parneet Kaur et al.   ACS Chemical Neuroscience

Association between diabetes and amyotrophic lateral sclerosis in Sweden

(2015) D. Mariosa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Potential Environmental Factors in Amyotrophic Lateral Sclerosis

(2015) Björn Oskarsson et al.   NEUROLOGIC CLINICS

Angiotensin-Converting Enzyme Inhibitors and Amyotrophic Lateral Sclerosis Risk

(2015) Feng-Cheng Lin et al.   JAMA Neurology

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis

(2015) Marianthi-Anna Kioumourtzoglou et al.   JAMA Neurology

Circulating Gonadal and Adrenal Steroids in Amyotrophic Lateral Sclerosis: Possible Markers of Susceptibility and Outcome

(2014) G. Gargiulo-Monachelli et al.   HORMONE AND METABOLIC RESEARCH

Controversies and priorities in amyotrophic lateral sclerosis

(2013) Martin R Turner et al.   LANCET NEUROLOGY

The epidemiology of ALS: a conspiracy of genes, environment and time

(2013) Ammar Al-Chalabi et al.   Nature Reviews Neurology

Amyotrophic lateral sclerosis: A hormonal condition?

(2012) Helene Blasco et al.   Amyotrophic Lateral Sclerosis

Use of Surveillance, Epidemiology, and End Results-Medicare Data to Conduct Case-Control Studies of Cancer Among the US Elderly

(2011) E. A. Engels et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

(2011) Peter M. Andersen et al.   Nature Reviews Neurology

Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders

(2010) R. Lee Mosley et al.   EXPERIMENTAL NEUROLOGY

Neuroprotective actions of brain aromatase

(2009) Colin J. Saldanha et al.   FRONTIERS IN NEUROENDOCRINOLOGY